Cord Blood Stem Cells Market
Cord Blood Stem Cells Market - Global Industry Assessment & Forecast
#
Pages:
145
2022
Aug - 2023
VMR-VMR-2021-0195
Segments Covered
By
Type Allogeneic Stem Cell , Autologous Stem Cell
-
By
Application Autoimmune Diseases , Immunodeficiencies , Malignancies , Caners , Solid Tumors
-
By
End User Therapeutics Service Companies, Private and Government Research Institutes, Academic Institutes, Research-Based Pharmaceutical Companies, Public and Private Cord Blood Banks, Others
-
By
Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
 Base Year:
|
2022 |
| Forecast
Years:
|
2023 - 2030 |
 Historical
Years:
|
2017 - 2021 |
 Revenue
2022: |
USD 1615 Million |
 Revenue 2030:
|
USD 2318.31 Million |
 Revenue CAGR
(2023 - 2030): |
5.3% |
Fastest Growing Region (2023 -
2030)
|
Asia Pacific |
Largest Region (2022):
|
North America |
Customization Offered
Cross-segment Market Size and
Analysis
for Mentioned Segments- Additional Company Profiles (Upto 5
With
No Cost)
- Additional Countries (Apart From
Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request
Customization Speak To
Analyst
Research Methodology: Cord Blood Stem Cells Market by Type by Application by End User by Region - Global Market Assessment, 2021 - 2028
Secondary Research
Primary Research:
Data Triangulation and Market Size Estimations
FAQ
Frequently Asked Question
What is the global demand for Cord Blood Stem Cells in terms of revenue?
-
The global Cord Blood Stem Cells valued at USD 1615 Million in 2022 and is expected to reach USD 2318.31 Million in 2030 growing at a CAGR of 5.3%.
Which are the prominent players in the market?
-
The prominent players in the market are BioCell Pty. Ltd., Kaneka Corporation, DomaniCell LLC, Future Health Technologies, Eticur, Advanced Cell Technology Inc., Banco De Celulas Madre, J.P. McCarthy Cord Stem Cell Bank, CyGenics Ltd, AlphaCord..
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 5.3% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Cord Blood Stem Cells include
- Increasing awareness about the therapeutic potential
Which region accounted for the largest share in the market?
-
North America was the leading regional segment of the Cord Blood Stem Cells in 2022.
